- No file added yet -

Induction of Sustained Clinical Remission in Early Axial Spondyloarthritis following Certolizumab Pegol Treatment: 48-Week Outcomes from C-OPTIMISE

figure

posted on 2020-06-02, 10:49 authored by Robert Landewé, Désirée van der Heijde, Maxime Dougados, Xenofon Baraliakos, Filip Van den Bosch, Karl Gaffney, Lars Bauer, Bengt Hoepken, Natasha de Peyrecave, Karen Thomas, Lianne S. Gensler

The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).